​Dr. Elizabeth Ann Stringer is a data-driven healthcare innovator and Chief Operating Officer at NashBio. As one of the first three team members at axialHealthcare, she served as Chief Science Officer, pioneering pain management solutions that helped scale the company to $20M in revenue and secure $16.5M in Series B funding. She led teams of 20+ analytics professionals developing risk-stratification models to combat the opioid crisis and improve patient outcomes across millions of lives.
Dr. Stringer completed her postdoctoral fellowship at Stanford School of Medicine and earned her PhD from Vanderbilt University’s Institute of Imaging Science.

​Margaret Davidson is a Principal at Company Ventures, where she works with Terrarium’s entrepreneurs-in-residence to ideate, validate, and build new health tech companies. She backs founders with a track record of execution who are obsessed with solving hard problems in markets where innovation has lagged. She began her career in global public health as a Peace Corps volunteer in Senegal, later leading digital transformation and workforce programs for the Colorado Community Health Network and founding a nationally distributed retail brand. Margaret has an MBA from Columbia Business School and a BA from Johns Hopkins University.

​Michelle Wang is a healthcare investor at Wavemaker 360. Previously, she was an operator across seed to growth and late-stage venture-backed startups, where she helped launch new businesses and grow existing business lines while navigating hypergrowth. She began her career in healthcare banking, where she’s supported dozens of transactions raising over $10bn in aggregate funding. Michelle has an MBA from Harvard Business School and a BA in Economics from the University of Chicago.

​​Jessie (Laurash) Gentil is a Principal at Health Enterprise Partners, a healthcare IT and services focused growth equity firm whose investors include leading hospital systems and health plans across the country. She joined HEP in 2017 while completing her MBA at Columbia Business School. Previously, Jessie was Director of Operations at MediQuire, a venture-backed healthcare data analytics company, and before that was with Evolent Health, where she helped delivery systems build population health management infrastructure. She began her career as a consultant at Booz Allen Hamilton focusing on healthcare policy and reform. Jessie is on the faculty at Columbia Business School and holds a BS in Biology of Global Health from Georgetown University.